Home/Neoclease/Chelsea Trengrove, PhD
CT

Chelsea Trengrove, PhD

CEO and Cofounder

Neoclease

Therapeutic Areas

Neoclease Pipeline

DrugIndicationPhase
LRRK2 NucleaseParkinson's DiseasePre-clinical